Caplin Point Laboratories Limited

Company Profile

Caplin Point Laboratories Limited had its IPO on under the ticker symbol CAPLIPOINT.

The company operates in the sector and industry. Caplin Point Laboratories Limited has a staff strength of 0 employees.

Stock update

Shares of Caplin Point Laboratories Limited opened at 1042.25 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of 961.95 - 1048.35, and closed at 971.75.

This is a -6.3% slip from the previous day's closing price.

A total volume of 271,291 shares were traded at the close of the day’s session.

In the last one week, shares of Caplin Point Laboratories Limited have slipped by -9.36%.

Caplin Point Laboratories Limited's Key Ratios

Caplin Point Laboratories Limited has a market cap of 0, indicating a price to book ratio of and a price to sales ratio of .

In the last 12-months Caplin Point Laboratories Limited’s revenue was 0 with a gross profit of 0 and an EBITDA of 0. The EBITDA ratio measures Caplin Point Laboratories Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Caplin Point Laboratories Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Caplin Point Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Caplin Point Laboratories Limited’s PE and PEG Ratio

Forward PE

Trailing PE

PEG

Its diluted EPS in the last 12-months stands at per share while it has a forward price to earnings multiple of and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Caplin Point Laboratories Limited’s profitability.

Caplin Point Laboratories Limited stock is trading at a EV to sales ratio of and a EV to EBITDA ratio of . Its price to sales ratio in the trailing 12-months stood at .

Caplin Point Laboratories Limited stock pays annual dividends of per share, indicating a yield of and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

0

Total Liabilities

0

Operating Cash Flow

0

Capital Expenditure

0

Dividend Payout Ratio

0%

Caplin Point Laboratories Limited ended 1970 with 0 in total assets and 0 in total liabilities. Its intangible assets were valued at 0 while shareholder equity stood at 0.

Caplin Point Laboratories Limited ended 1970 with 0 in deferred long-term liabilities, 0 in other current liabilities, in common stock, 0 in retained earnings and 0 in goodwill. Its cash balance stood at 0 and cash and short-term investments were 0. The company’s total short-term debt was 0 while long-term debt stood at 0.

Caplin Point Laboratories Limited’s total current assets stands at 0 while long-term investments were 0 and short-term investments were 0. Its net receivables were 0 compared to accounts payable of 0 and inventory worth 0.

In 1970, Caplin Point Laboratories Limited's operating cash flow was 0 while its capital expenditure stood at 0.

Comparatively, Caplin Point Laboratories Limited paid 0 in dividends in 1970.

Other key metrics

Current Trading Price

971.75

52-Week High

52-Week Low

Analyst Target Price

Caplin Point Laboratories Limited stock is currently trading at 971.75 per share. It touched a 52-week high of and a 52-week low of . Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was 950.27 and 200-day moving average was 764.99 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.